- Home
- CCCS vs HALO Comparison
CCCS vs HALO Comparison
Compare CCCS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCS
- HALO
- Stock Information
- Founded
- CCCS 1980
- HALO 1998
- Country
- CCCS United States
- HALO United States
- Employees
- CCCS N/A
- HALO N/A
- Industry
- CCCS Computer Software: Prepackaged Software
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCCS Technology
- HALO Health Care
- Exchange
- CCCS Nasdaq
- HALO Nasdaq
- Market Cap
- CCCS 7.4B
- HALO 6.4B
- IPO Year
- CCCS N/A
- HALO N/A
- Fundamental
- Price
- CCCS $11.09
- HALO $56.87
- Analyst Decision
- CCCS Buy
- HALO Buy
- Analyst Count
- CCCS 9
- HALO 9
- Target Price
- CCCS $13.89
- HALO $60.89
- AVG Volume (30 Days)
- CCCS 4.3M
- HALO 1.4M
- Earning Date
- CCCS 02-26-2025
- HALO 02-18-2025
- Dividend Yield
- CCCS N/A
- HALO N/A
- EPS Growth
- CCCS N/A
- HALO 61.71
- EPS
- CCCS 0.07
- HALO 3.02
- Revenue
- CCCS $926,937,000.00
- HALO $947,355,000.00
- Revenue This Year
- CCCS $11.08
- HALO $23.48
- Revenue Next Year
- CCCS $9.00
- HALO $18.16
- P/E Ratio
- CCCS $155.73
- HALO $18.78
- Revenue Growth
- CCCS 10.10
- HALO 21.35
- 52 Week Low
- CCCS $9.79
- HALO $33.64
- 52 Week High
- CCCS $12.88
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- CCCS 37.47
- HALO 69.30
- Support Level
- CCCS $10.81
- HALO $54.96
- Resistance Level
- CCCS $11.27
- HALO $57.46
- Average True Range (ATR)
- CCCS 0.25
- HALO 1.30
- MACD
- CCCS -0.01
- HALO 0.02
- Stochastic Oscillator
- CCCS 18.68
- HALO 79.77
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.